This inventor holds 8 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America, The University of North Carolina at Chapel Hill. Active years: 1992-2024.
Location History:
- Rockville, MD (US) (1992 - 1997)
- Gaithersburg, MD (US) (1999 - 2017)
- Bethesda, MD (US) (2023)
Company Filing History:
4 out of 3,688 
2 out of 255 
2 out of 1,324 
Years Active: 1992-2024
Title: David Robert Sibley: Innovator in Dopamine Receptor Research
Introduction
David Robert Sibley is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of pharmacology, particularly in the development of selective dopamine receptor agonists. With a total of 8 patents to his name, Sibley's work has the potential to impact the treatment of various neurological disorders.
Latest Patents
Sibley's latest patents include groundbreaking research on selective D3 dopamine receptor agonists and methods of their use. One of the key disclosures involves a compound of Formula I or a pharmaceutically acceptable salt thereof. This research provides methods for treating patients with Parkinson's disease and related syndromes, dyskinesia, neurodegenerative disorders such as Alzheimer's disease, and other cognitive dysfunctions. The patents also explore combination methods of treatment, where the compound is administered alongside additional active agents.
Career Highlights
Throughout his career, David Robert Sibley has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His research has been instrumental in advancing our understanding of dopamine receptors and their role in various medical conditions.
Collaborations
Sibley has collaborated with notable colleagues such as Frederick J Monsma, Jr. and Marc Ferrer. These partnerships have further enriched his research and contributed to the development of innovative therapeutic approaches.
Conclusion
David Robert Sibley stands out as a key figure in the field of dopamine receptor research, with a focus on developing effective treatments for neurological disorders. His contributions continue to shape the landscape of pharmacological innovation.